Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/28/2000WO2000078794A1 Cysteinyl protease inhibitors
12/28/2000WO2000078792A1 Method for purification of proteins
12/28/2000WO2000078779A2 N-pyrazole a2a receptor agonists
12/28/2000WO2000078777A1 Propargyl phenyl ether a2a receptor agonists
12/28/2000WO2000078776A2 Thiophene a2a receptor agonists
12/28/2000WO2000078768A1 Potassium channel openers
12/28/2000WO2000078767A1 Thienopyrimidines as phosphodiesterase inhibitors
12/28/2000WO2000078762A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists
12/28/2000WO2000078758A1 Novel imidazole derivatives
12/28/2000WO2000078757A1 Inhibitors of il-12 production
12/28/2000WO2000078750A1 New pharmaceutically active compounds
12/28/2000WO2000078746A1 Antiviral agents
12/28/2000WO2000078742A1 Chroman derivatives against neurological disorders
12/28/2000WO2000078738A1 Melamine derivatives as potent anti-cancer agents
12/28/2000WO2000078736A1 1,4-diazacycloheptane derivatives as neuroprotective agents
12/28/2000WO2000078731A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000WO2000078720A1 Novel dihydropyridine derivative
12/28/2000WO2000078719A1 Dihydropyridine derivative
12/28/2000WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans
12/28/2000WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS
12/28/2000WO2000078708A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000WO2000078396A2 Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
12/28/2000WO2000078344A1 Prion protein peptides and uses thereof
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078339A1 Uterine contraction inhibitors
12/28/2000WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078317A1 Integrin receptor antagonists
12/28/2000WO2000078313A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000WO2000078310A1 Indole compounds
12/28/2000WO2000078299A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
12/28/2000WO2000078259A1 Enhanced wound coverage to enhance wound healing
12/28/2000WO2000078143A1 Method of increasing the content of flavonoids and phenolic substances in plants
12/28/2000WO2000056301A3 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000045845A3 Liposome composition and method for administration of a radiosensitizer
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000031093A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000DE19929065A1 Synergistic drug combination, especially for treating cardiovascular diseases associated with metabolic disorders, comprising bi- or tricyclic aza-heterocyclic MTP inhibitor and HMG-CoA reductase inhibitor
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377648A1 Prion protein peptides and uses thereof
12/28/2000CA2377371A1 Enhanced wound coverage to enhance wound healing
12/28/2000CA2377246A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2376077A1 Integrin receptor antagonists
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375414A1 Human transcriptional regulator proteins
12/28/2000CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000CA2375312A1 Melamine derivatives as potent anti-cancer agents
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375278A1 Thienopyrimidines
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions
12/28/2000CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2375207A1 Peptide having preptin functionality
12/28/2000CA2375182A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000CA2374002A1 Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000CA2341542A1 .alpha.1b-adrenergic receptor antagonists
12/28/2000CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063228A1 Cycloalkene derivatives, process for producing the same, and use
12/27/2000EP1062349A2 Diisopropyl fluorophosphatase and the utilization and production thereof
12/27/2000EP1062332A2 Human receptor proteins; related reagents and methods
12/27/2000EP1062326A1 Glycosyl sulfotransferase-3
12/27/2000EP1062323A2 Methods of diagnosis and triage using cell activation measures
12/27/2000EP1062322A2 A living chimeric skin replacement
12/27/2000EP1062321A1 Uses for humane non-autologous mesenchymal stem cells
12/27/2000EP1062264A2 Enzyme inhibitors
12/27/2000EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies
12/27/2000EP1062232A2 Molecules that home to various selected organs or tissues
12/27/2000EP1062228A1 Plasminogen-related gene b polypeptides
12/27/2000EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
12/27/2000EP1062224A1 Modified factor viii
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062209A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
12/27/2000EP1062206A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
12/27/2000EP1062205A2 Inhibitors of phospholipase enzymes
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1062201A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
12/27/2000EP1061961A1 Apparatuses and processes for whole-body hyperthermia
12/27/2000EP1061953A1 Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
12/27/2000EP1061951A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
12/27/2000EP1061946A1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/27/2000EP1061944A2 Therapeutic chemokine receptor antagonists
12/27/2000EP1061943A1 Method of preventing the death of retinal neurons and treating ocular diseases
1 ... 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 ... 1564